🇳🇱 Netherlands Country × Condition
type 2 diabetes Clinical Trials in Netherlands
Active clinical trials for type 2 diabetes with research sites in Netherlands. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 4 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇳🇱 Netherlands
Active Trials in Netherlands (3)
NCT05651724
Recruiting
Global Research Initiative for Patients Screening on MASH
Enrollment
10,000 pts
Country
🇳🇱 Netherlands
Julius Clinical
View Trial → NCT06384313
Recruiting
Butyrate-enriched Triglyceride and Diabetes Prevention
Enrollment
48 pts
Country
🇳🇱 Netherlands
Maastricht University Medical Cente...
View Trial → NCT06983054 Phase 4
Recruiting
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes
Enrollment
34 pts
Country
🇳🇱 Netherlands
Amsterdam UMC, location VUmc
View Trial → Frequently Asked Questions
How many type 2 diabetes clinical trials are active in Netherlands?
There are currently 3 active clinical trials for type 2 diabetes with sites in Netherlands, of which 3 are actively recruiting patients.
How can I join a type 2 diabetes clinical trial in Netherlands?
To join a type 2 diabetes clinical trial in Netherlands, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Netherlands directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are type 2 diabetes trials in Netherlands?
Active type 2 diabetes trials in Netherlands span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology